Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

News

Author: Johanna Stiefler JohnsonPublished: 14 January 2021

Prep: Cook: Serves:

female doctor is measuring senior man's body circumference

Researchers at the University of Pennsylvania, US, have found that people with early Parkinson’s disease are at higher risk of developing cognitive impairments if they are overweight, have disruptive sleep behaviours or experience symptoms of depression.

Evaluating data from 405 people, the researchers used statistical analysis to identify relationships between certain characteristics and changes in patient cognition over time. Their findings suggest that factors such as high body mass index (BMI) or excessive sleepiness are associated with a faster rate of cognitive decline in Parkinson’s disease.

The researchers wrote: “Despite its common and devastating occurrence, treatment of [cognitive impairments] in [Parkinson’s disease] is limited and no medications slow its onset or progression. However, identification of treatable or modifiable comorbidities that affect the rate of progression of [cognitive impairments] in [Parkinson’s disease] could provide opportunities for early intervention and improved prognosis.”

For more information about the latest Parkinson’s disease research, please visit the EPDA website.

Find out more about factors associated with cognitive decline in Parkinson’s disease.

Can equine-assisted therapy benefit people with Parkinson’s disease?

Last Month

Next Month

Go Back

Share this story

Comments

Recipes & Nutrition

How a good diet can alleviate anxiety and panic disorders in Parkinson’s

Could a better diet help prevent anxiety in Parkinson’s?

Ask the expert: How can hallucinations affect people with Parkinson’s?

Professor Per Odin shares need-to-know information on the symptom

Helping people with Parkinson’s “take back control of their brain and body”

We talk to the founder of MyCognition

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

News

Author: Johanna Stiefler JohnsonPublished: 14 January 2021

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Recipes & Nutrition

How a good diet can alleviate anxiety and panic disorders in Parkinson’s

Special reports

Ask the expert: How can hallucinations affect people with Parkinson’s?

Resources & Tools

Helping people with Parkinson’s “take back control of their brain and body”

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

News

Author: Johanna Stiefler JohnsonPublished: 14 January 2021

Last Month

Next Month

Share this story

Comments

Related articles

Recipes & Nutrition

How a good diet can alleviate anxiety and panic disorders in Parkinson’s

Special reports

Ask the expert: How can hallucinations affect people with Parkinson’s?

Resources & Tools

Helping people with Parkinson’s “take back control of their brain and body”

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in